Ospemifene
Indication
Vulvovaginal or vaginal atrophy in postmenopausal women
Black
Brand:
Senshio®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Genito-urinary system
Background
Ospemifene is considerably more expensive than other products available to treat vulvar and vaginal atrophy. No direct evidence is available to make comparison with currently available products.
Recommendation
LSCMMG Recommendation:
Black
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria
Supporting documents: